🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
1. Objectives and Hypothesis 1. Objectives: This study evaluates...
Status
Unknown
Location
Jichi Medical Univercity
Start Date
2010-10
Trial ID
NCT01198496
Treatments Being Tested
The purpose of this study is to evaluate the non-inferiority clinical effic...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-11
Trial ID
NCT02521233
To compare the changes in mean sitting DBP from baseline after 4 weeks of t...
Status
Completed
Location
Research Site
Start Date
2008-02
Trial ID
NCT00621153
Treatments Being Tested
The aim is to compare the blood pressure lowering effect of the combination...
Status
Completed
Location
Research Site
Start Date
2007-01
Trial ID
NCT00434967
Treatments Being Tested
The CandLE study with at maximum daily dose of 32 mg candesartan or 16/12.5...
Status
Completed
Location
Multiple Locations
Start Date
2007-01
Trial ID
NCT00607633
The purpose of this study is to see if Candesartan, once daily (QD), added ...
Status
Completed
Location
Multiple Locations
Start Date
2009-10
Trial ID
NCT01012479
Treatments Being Tested
The purpose of this study is to examine the effects of blood pressure medic...
Status
Completed
Location
University of Southern California
Start Date
2008-01
Trial ID
NCT00605072
Treatments Being Tested
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus res...
Status
Completed
Location
University of Utah
Start Date
2020-01-19
Trial ID
NCT04467931
Treatments Being Tested
This study is required to confirm the suitability of a candidate FDC of 16m...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-04-17
Trial ID
NCT02094924
Treatments Being Tested
Angiotensin receptor antagonists (ARA), beta-blockers and diuretics do not ...
Status
Completed
Location
Institut de Recherches Cliniques de Montréal
Start Date
2003-12
Trial ID
NCT00232882
Treatments Being Tested